Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated:  12/2/2013
Duke University
mi
from
Durham, NC
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated: 12/2/2013
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated:  12/2/2013
Oregon Health and Science University
mi
from
Portland, OR
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated: 12/2/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated:  12/2/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated: 12/2/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated:  12/2/2013
Baylor College of Medicine
mi
from
Houston, TX
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated: 12/2/2013
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated:  12/2/2013
University of Utah
mi
from
Salt Lake City, UT
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome
Status: Enrolling
Updated: 12/2/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
A Randomized Prospective Clinical Trial of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
Status: Enrolling
Updated:  12/2/2013
Carrick Brain Centers
mi
from
Irving, TX
Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
A Randomized Prospective Clinical Trial of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
Status: Enrolling
Updated: 12/2/2013
Carrick Brain Centers
mi
from
Irving, TX
Click here to add this to my saved trials
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Status: Enrolling
Updated:  12/4/2013
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
Status: Enrolling
Updated: 12/4/2013
VA Eastern Colorado Health Care System, Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Advancing Telestroke Care: A Prospective Observational Study
Advancing Telestroke Care: A Prospective Observational Study
Status: Enrolling
Updated:  12/4/2013
University of Southern California
mi
from
Los Angeles, CA
Advancing Telestroke Care: A Prospective Observational Study
Advancing Telestroke Care: A Prospective Observational Study
Status: Enrolling
Updated: 12/4/2013
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of the Veterans' In-home Program
Evaluation of the Veterans' In-home Programs for Veterans With TBI and Families
Status: Enrolling
Updated:  12/6/2013
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Evaluation of the Veterans' In-home Program
Evaluation of the Veterans' In-home Programs for Veterans With TBI and Families
Status: Enrolling
Updated: 12/6/2013
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Diagnostic Endoscopic Exploration for Pancreatic Head Mass
Human Clinical Trial of Diagnostic Transgastric Endoscopic Peritoneoscopy for Staging of Pancreatic Head Mass
Status: Enrolling
Updated:  12/9/2013
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Diagnostic Endoscopic Exploration for Pancreatic Head Mass
Human Clinical Trial of Diagnostic Transgastric Endoscopic Peritoneoscopy for Staging of Pancreatic Head Mass
Status: Enrolling
Updated: 12/9/2013
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
University of Alabama at Birmingham
mi
from
Birminham, AL
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
University of Alabama at Birmingham
mi
from
Birminham, AL
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
UCLA Mattel Children's Hospital
mi
from
Los Angeles, CA
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
UCLA Mattel Children's Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
Jack & Julia Center for TSC at Oakland Children's Hospital & Research Center
mi
from
Oakland, CA
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
Jack & Julia Center for TSC at Oakland Children's Hospital & Research Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
Kennedy Krieger Institute
mi
from
Baltimore, MD
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
Herscot Center for Adults and Children with TSC Massachusetts General Hospital
mi
from
Boston, MA
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
Herscot Center for Adults and Children with TSC Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
Clinic Without Walls
mi
from
Saint Paul, MN
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
Clinic Without Walls
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
Texas Scottish Rite Hospital
mi
from
Dallas, TX
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
Texas Scottish Rite Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated:  12/9/2013
University of Texas Medical School in Houston
mi
from
Houston, TX
Topical Rapamycin to Erase Angiofibromas in TSC
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Status: Enrolling
Updated: 12/9/2013
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain
The Efficacy and Mechanisms of Cognitive Therapy Compared to Mindfulness-Based Cognitive Therapy in Multiple Sclerosis (MS) Pain
Status: Enrolling
Updated:  12/9/2013
UW Medicine Multiple Sclerosis Center
mi
from
Seattle, WA
Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain
The Efficacy and Mechanisms of Cognitive Therapy Compared to Mindfulness-Based Cognitive Therapy in Multiple Sclerosis (MS) Pain
Status: Enrolling
Updated: 12/9/2013
UW Medicine Multiple Sclerosis Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Status: Enrolling
Updated:  12/9/2013
Kessler Institute for Rehabiliation
mi
from
West Orange, NJ
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Status: Enrolling
Updated: 12/9/2013
Kessler Institute for Rehabiliation
mi
from
West Orange, NJ
Click here to add this to my saved trials
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Status: Enrolling
Updated:  12/9/2013
Memorial Hermann Hospital
mi
from
Houston, TX
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
Status: Enrolling
Updated: 12/9/2013
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
A Placebo Controlled Study to Estimate the Effect Size of Glutamine as a Supplement to Prevent Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma Patients
Status: Enrolling
Updated:  12/10/2013
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
A Placebo Controlled Study to Estimate the Effect Size of Glutamine as a Supplement to Prevent Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma Patients
Status: Enrolling
Updated: 12/10/2013
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)
Clevidipine for Vasospasm After Subarachnoid Hemorrhage
Status: Enrolling
Updated:  12/10/2013
Henry Ford Hospital
mi
from
Detroit, MI
Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)
Clevidipine for Vasospasm After Subarachnoid Hemorrhage
Status: Enrolling
Updated: 12/10/2013
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery
TDCS-enhanced Stroke Recovery and Cortical Reorganization
Status: Enrolling
Updated:  12/11/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery
TDCS-enhanced Stroke Recovery and Cortical Reorganization
Status: Enrolling
Updated: 12/11/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
Johns Hopkins University
mi
from
Baltimore, MD
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
University of Maryland
mi
from
Baltimore, MD
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
Univ of North Carolina
mi
from
Chapel Hill, NC
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effects of Bright Light Therapy in Mild Traumatic Brain Injury
Effects of Bright Light Therapy of Sleep, Cognition, Brain Function, and Neurochemistry in Mild Traumatic Brain Injury
Status: Enrolling
Updated:  12/20/2013
McLean Hospital
mi
from
Belmont, MA
Effects of Bright Light Therapy in Mild Traumatic Brain Injury
Effects of Bright Light Therapy of Sleep, Cognition, Brain Function, and Neurochemistry in Mild Traumatic Brain Injury
Status: Enrolling
Updated: 12/20/2013
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Cortical and Biomechanical Dynamics of Ankle Robotics Training in Stroke
Cortical and Biomechanical Dynamics of Ankle Robotics Training in Stroke
Status: Enrolling
Updated:  1/7/2014
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Cortical and Biomechanical Dynamics of Ankle Robotics Training in Stroke
Cortical and Biomechanical Dynamics of Ankle Robotics Training in Stroke
Status: Enrolling
Updated: 1/7/2014
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device
FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device
Status: Enrolling
Updated:  1/8/2014
University of Delaware - STAR Campus
mi
from
Newark, DE
FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device
FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device
Status: Enrolling
Updated: 1/8/2014
University of Delaware - STAR Campus
mi
from
Newark, DE
Click here to add this to my saved trials
Testing the Efficacy of Self-Generation Treatment Protocol
Exploring the Effects of a Memory Intervention on Memory and Everyday Life Activities With Persons With MS
Status: Enrolling
Updated:  1/9/2014
Kessler Foundation
mi
from
West Orange, NJ
Testing the Efficacy of Self-Generation Treatment Protocol
Exploring the Effects of a Memory Intervention on Memory and Everyday Life Activities With Persons With MS
Status: Enrolling
Updated: 1/9/2014
Kessler Foundation
mi
from
West Orange, NJ
Click here to add this to my saved trials
Safety Study of Nicardipine to Treat Cerebral Vasospasm
Intraventricular Nicardipine for the Treatment of Cerebral Vasospasm: Prospective Pilot Study
Status: Enrolling
Updated:  1/13/2014
University of Florida
mi
from
Gainesville, FL
Safety Study of Nicardipine to Treat Cerebral Vasospasm
Intraventricular Nicardipine for the Treatment of Cerebral Vasospasm: Prospective Pilot Study
Status: Enrolling
Updated: 1/13/2014
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Pilot Study of Free From Falls Program in Multiple Sclerosis
Pilot Study on the Effect of the Free From Falls Program on Falls in People With Multiple Sclerosis
Status: Enrolling
Updated:  1/13/2014
Oregon Health and Science University and Portland VA Medical Center
mi
from
Portland, OR
Pilot Study of Free From Falls Program in Multiple Sclerosis
Pilot Study on the Effect of the Free From Falls Program on Falls in People With Multiple Sclerosis
Status: Enrolling
Updated: 1/13/2014
Oregon Health and Science University and Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Safety of Intravenous Thrombolytics in Stroke on Awakening
Safety of Intravenous Thrombolytics in Stroke on Awakening
Status: Enrolling
Updated:  1/16/2014
Anne Arundel Medical Center
mi
from
Annapolis, MD
Safety of Intravenous Thrombolytics in Stroke on Awakening
Safety of Intravenous Thrombolytics in Stroke on Awakening
Status: Enrolling
Updated: 1/16/2014
Anne Arundel Medical Center
mi
from
Annapolis, MD
Click here to add this to my saved trials
Safety of Intravenous Thrombolytics in Stroke on Awakening
Safety of Intravenous Thrombolytics in Stroke on Awakening
Status: Enrolling
Updated:  1/16/2014
Johns Hopkins Hospital
mi
from
Baltimore, MD
Safety of Intravenous Thrombolytics in Stroke on Awakening
Safety of Intravenous Thrombolytics in Stroke on Awakening
Status: Enrolling
Updated: 1/16/2014
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety of Intravenous Thrombolytics in Stroke on Awakening
Safety of Intravenous Thrombolytics in Stroke on Awakening
Status: Enrolling
Updated:  1/16/2014
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Safety of Intravenous Thrombolytics in Stroke on Awakening
Safety of Intravenous Thrombolytics in Stroke on Awakening
Status: Enrolling
Updated: 1/16/2014
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative site
mi
from
Los Angeles, CA
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative Site
mi
from
Newport Beach, CA
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative Site
mi
from
Sacramento, CA
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative site
mi
from
Aurora, CO
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative site
mi
from
Aurora, CO
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative Site
mi
from
Danbury, CT
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative Site
mi
from
Danbury, CT
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative Site
mi
from
Miami, FL
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative Site
mi
from
Pompano Beach, FL
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative Site
mi
from
Pompano Beach, FL
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigational Site
mi
from
Tampa, FL
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative Site
mi
from
Atlanta, GA
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigator Site
mi
from
Chicago, IL
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigator Site
mi
from
Chicago, IL
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated:  1/17/2014
Novartis Investigative Site
mi
from
Kansas City, KA
FTY720 in Patients With Primary Progressive Multiple Sclerosis
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 1/17/2014
Novartis Investigative Site
mi
from
Kansas City, KA
Click here to add this to my saved trials